Education
About Us
Working with TipRanks
Follow Us
Ispire Technology, Inc. (ISPR)
NASDAQ:ISPR
Top Page
Ispire Technology, Inc.
(NASDAQ:ISPR)
Select Model
Select Model
Rating:46Neutral
Price Target:
$2.00
▼(-11.89% Downside)
Action:ReiteratedDate:02/21/26
Overall score reflects pressured financials (losses, cash burn, and negative equity) and bearish technicals (below major moving averages with negative MACD). The latest earnings call provides some offset via cost discipline and improved collections plus guidance for improvement, but the sharp revenue decline and liquidity/cash-flow risks keep the score below average.
Positive Factors
Improved collections / DSO
Material improvement in receivables and collections strengthens working capital conversion and lowers short-term financing needs. Better cash collection reduces liquidity stress, improves runway for strategic investments, and supports operational stability while revenue recovers.
Cost discipline and lower cash burn
Sustained reductions in opex and minimal H2 operating cash burn indicate durable operating leverage and management focus on cash efficiency. Lower fixed costs improve flexibility to invest in growth initiatives without rapidly increasing external funding needs.
Tech & capacity build (iQTEC, Gmesh, Malaysia)
Proprietary age-gating tech, superconductive-glass hardware interest, and a major manufacturing build-out form structural competitive advantages. These create differentiated IP, higher-volume capacity, and partner appeal that can support durable B2B revenue scale if commercialized.
Negative Factors
Negative stockholders' equity
Negative equity signals multiyear losses that erode the capital base, constraining borrowing capacity and increasing the likelihood of dilution. It weakens balance-sheet resilience and limits strategic options during revenue troughs or investment cycles.
Persistent cash-flow deficits
Sustained negative operating and free cash flow forces reliance on external funding or asset sales, raising execution risk for capacity projects and tech commercialization. Continued cash depletion narrows runway and can trigger dilution or deferred investments.
Sharp revenue decline & regulatory dependency
A >50% revenue decline reduces scale-driven margins and stresses fixed costs; the recovery depends on regulatory approvals and timing for age-gating and partner launches. This creates execution and timing risk for converting capacity and tech into sustained revenue growth.
Ispire Technology, Inc. (ISPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$157.55M
Dividend YieldN/A
Average Volume (3M)44.30K
Price to Earnings (P/E)―
Beta (1Y)0.89
Revenue Growth-20.13%
EPS Growth-88.66%
CountryUS
Employees98
SectorConsumer Defensive
Sector Strength42
IndustryTobacco
Share Statistics
EPS (TTM)-0.12
Shares Outstanding57,289,864
10 Day Avg. Volume39,789
30 Day Avg. Volume44,298
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)240.69
Price to Sales (P/S)1.14
P/FCF Ratio-17.17
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue1.25
Enterprise Value/Gross Profit7.62
Enterprise Value/Ebitda-11.84
Forecast
1Y Price Target
$6.50Price Target Upside186.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ispire Technology, Inc. Business Overview & Revenue Model
Company DescriptionIspire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited
How the Company Makes MoneyIspire Technology generates revenue through a multifaceted business model that includes the sale of software licenses, subscription-based services, and hardware products. Key revenue streams consist of recurring subscriptions for cloud services and cybersecurity solutions, along with one-time fees from software licensing. Additionally, the company has established significant partnerships with major cloud service providers and enterprise resource planning (ERP) systems, allowing for bundled offerings that enhance its market reach. This strategic positioning, combined with ongoing investments in research and development, helps Ispire Technology capitalize on emerging market trends and client needs, contributing to its overall profitability.
Ispire Technology, Inc. Key Performance Indicators (KPIs)
Ispire Technology, Inc. Earnings Call Summary
Earnings Call Date:Feb 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:May 19, 2026
Earnings Call Sentiment Neutral
The call portrayed a company at an operational inflection point: management highlighted meaningful improvements in collections, expense control, and strategic positioning (age-gating technology, Gmesh, Malaysian capacity) that set the stage for future revenue recovery. However, near-term financials remain challenged — revenue and gross profit were cut roughly in half year-over-year, cash balances declined, and operating cash flow was negative on a six-month basis. The progress on technology partnerships and regulatory engagement is promising but subject to timing and approval risk. Overall, the tone is cautiously optimistic with clear near-term headwinds.Q2-2026 Updates
Positive Updates
Accounts Receivable and Collections Improvement
Net accounts receivable improved to $37.9M from $47.0M (down ~$9.1M, ~19.4%) and days sales outstanding improved by 8 days. Cash collected versus revenue for calendar year 2025 was 116% versus 67% in 2024 (an increase of 49 percentage points), indicating materially improved collections.
Operating Expense Reductions
Operating expenses were reduced to $10.3M from $15.1M year-over-year, a decline of $4.8M (~31.8%), reflecting successful cost-cutting and disciplined expense management.
Lower Net Loss
Net loss narrowed to $6.6M from $8.0M in the prior-year quarter (improvement of $1.4M, ~17.5%). For the six months ended 12/31/2025, net loss was reduced by $3.7M year-over-year.
Minimal Operating Cash Burn in H2 2025
From April 2025 through year-end, the company burned only $1.0M in operating cash as cost reductions and customer quality initiatives took hold, signaling improved cash discipline.
Strategic Pivot to Higher-Quality Nicotine Customers
Management intentionally shifted away from lower-value cannabis and slower-paying customers toward higher-value nicotine sector clients; this strategy drove improved receivables and collection metrics, though it reduced near-term top-line revenue.
Progress on iQTEC Age-Gating Technology and Regulatory Engagement
iQTEC advanced its component PMTA (submitted May 2024), received growing industry interest, was invited to an FDA small manufacturers roundtable, and reported a development deal (Charlie’s) slated to launch in 2–3 months with initial chip volumes of ~2–3M/month and an aspirational ramp toward 10M devices/month.
Gmesh Technology and Malaysian Manufacturing Build-Out
Gmesh superconductive-glass vaping hardware is attracting commercial interest; Malaysian facility build-out is on track to expand capacity from 6 production lines to 80 lines, aligning manufacturing with the company’s strategic pivot.
Improved Investing/Financing Cash Trends
Net cash used in investing activity for the first half was $0.9M (vs $1.1M prior-year) and financing cash use was modest ($0.7M), indicating limited near-term capital spending.
Negative Updates
Sharp Revenue Decline
Total revenue fell to $20.3M from $41.8M year-over-year, a decline of $21.5M (~51.4%), driven by the deliberate exit of lower-value customers and mix shift away from cannabis products.
Drop in Gross Profit and Slight Margin Compression
Gross profit declined to $3.5M from $7.7M (~54.5% decrease). Gross margin decreased to 17.1% from 18.5% (down 1.4 percentage points), primarily due to product mix with fewer higher-margin products sold.
Decline in Cash Balance
Cash on hand decreased to $17.6M from $24.4M at 06/30/2025, a reduction of $6.8M (~27.9%), signaling tighter liquidity compared with the prior half-year period.
Operating Cash Flow Turned Negative Year-to-Date
Net cash flow used in operating activities was $5.2M over the six-month period to December 31, 2025, versus $0.4M provided in the prior-year six-month period—a meaningful deterioration in operating cash flow on a YTD basis.
Near-Term Revenue Timing and Dependency on Regulatory Outcomes
Management does not expect immediate volume uplift this quarter from age-gating initiatives; broader commercialization and revenue depend on regulatory approvals (FDA PMTA outcomes) and successful rollouts, creating timing and execution risk.
Continued Illicit Market Headwinds and Chinese Supply Volatility
The U.S. nicotine market remains dominated by illicit products (management estimated >90% illicit), and Chinese export dynamics (VAT refund changes) created export spikes and pricing/volume pressure, representing ongoing sector headwinds.
Uncertainty Around Global Mandates and Funding Needs
Although regulatory interest is rising, no country has fully implemented age-gating mandates yet (some discussions under NDA). The iQTEC JV may require additional capital to scale globally, implying potential dilution or financing needs.
Company Guidance
Management guided that fiscal 2026 should deliver continued top‑line growth, consistent cash flow and bottom‑line improvement and said the recent trends should continue through the year; key metrics cited include Q2 revenue of $20.3M (vs. $41.8M prior year), gross profit $3.5M (vs. $7.7M) and gross margin 17.1% (vs. 18.5%), operating expenses down to $10.3M (from $15.1M), net loss narrowed to $6.6M (from $8.0M) with a six‑month year‑over‑year net loss improvement of $3.7M, net accounts receivable improved to $37.9M (from $47.0M), cash collected versus revenue 116% for calendar 2025 (vs. 67% in 2024), days‑sales‑outstanding improved by eight days, operating cash burn was only $1.0M from April–Dec 2025, cash on hand $17.6M (vs. $24.4M at 6/30/2025), net cash used in operating activities $5.2M (vs. $0.4M provided prior year six months), investing cash used $0.9M (vs. $1.1M) and financing cash used $0.7M (vs. $0), and management also highlighted operational catalysts including a Malaysian facility expansion from six to 80 production lines and an iQTEC/partner launch initially targeting 2–3M chips/month with a goal of up to 10M devices/month within 12 months.Ispire Technology, Inc. Financial Statement Overview
Summary
Weak fundamentals: TTM revenue is down ~18%, profitability is deeply negative (negative EBIT/EBITDA and large net loss), and operating/free cash flow are significantly negative. Balance-sheet risk is elevated with negative stockholders’ equity, increasing financing/dilution risk despite modest absolute debt.Income Statement
TTM (Trailing-Twelve-Months) revenue declined materially (down ~18%), and profitability remains weak: gross margin is in the mid-teens while operating results are deeply negative (EBIT and EBITDA both negative) with a large net loss. Annual results show a sharp deterioration from FY2024 to FY2025, with losses widening significantly and margins compressing. The main positive is that the company has demonstrated the ability to scale revenue in earlier years (FY2023–FY2024 growth), but the latest trajectory reflects weakening demand and limited operating leverage.24
Negative
Balance Sheet
Balance sheet risk increased meaningfully. TTM (Trailing-Twelve-Months) stockholders’ equity is negative, which reduces financial flexibility and makes leverage harder to interpret; debt is modest in absolute terms, but negative equity is a key red flag. In FY2025, leverage was very elevated versus a small equity base, a major shift from FY2024–FY2023 when equity was sizable and debt levels were low. Overall, assets remain substantial, but the equity deterioration points to ongoing losses pressuring the capital structure.18
Very Negative
Cash Flow
Cash generation is a clear weakness: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both significantly negative, indicating the business is consuming cash. While free cash flow was slightly better than net income (cash burn not worse than reported losses), the company still requires funding to support operations. Earlier years show that positive cash flow was possible (FY2021), but the multi-year pattern since then has been persistent cash outflows.22
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.97M | 127.49M | 151.91M | 115.61M | 88.10M | 63.41M |
| Gross Profit | 15.85M | 22.65M | 29.78M | 20.78M | 13.31M | 10.42M |
| EBITDA | -10.20M | -35.76M | -12.18M | -3.40M | -843.13K | 3.96M |
| Net Income | -35.51M | -39.24M | -14.77M | -6.00M | -1.87M | 2.94M |
Balance Sheet | ||||||
| Total Assets | 84.40M | 102.22M | 122.64M | 90.40M | 100.74M | 93.86M |
| Cash, Cash Equivalents and Short-Term Investments | 17.62M | 24.35M | 35.07M | 49.43M | 74.48M | 85.25M |
| Total Debt | 8.32M | 7.06M | 3.40M | 3.91M | 347.54K | 478.11K |
| Total Liabilities | 92.06M | 101.61M | 88.18M | 58.93M | 88.97M | 80.11M |
| Stockholders Equity | -7.66M | 604.69K | 34.46M | 31.47M | 11.77M | 13.76M |
Cash Flow | ||||||
| Free Cash Flow | -25.09M | -8.47M | -21.45M | -8.60M | -7.68M | 5.02M |
| Operating Cash Flow | -24.27M | -7.37M | -18.30M | -7.58M | -7.56M | 5.02M |
| Investing Cash Flow | -5.44M | -5.20M | 2.99M | -10.15M | -121.52K | -798.00 |
| Financing Cash Flow | 3.77M | 1.85M | 10.08M | -16.44M | -3.09M | -227.85K |
Ispire Technology, Inc. Technical Analysis
Negative
2.27
Price Trends
2.93
Negative
2.57
Negative
2.69
Negative
Market Momentum
-0.06
Positive
33.14
Neutral
2.57
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ISPR, the sentiment is Negative. The current price of 2.27 is below the 20-day moving average (MA) of 3.18, below the 50-day MA of 2.93, and below the 200-day MA of 2.69, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 33.14 is Neutral, neither overbought nor oversold. The STOCH value of 2.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ISPR.
Ispire Technology, Inc. Risk Analysis
Ispire Technology, Inc. disclosed 47 risk factors in its most recent earnings report. Ispire Technology, Inc. reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ispire Technology, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $2.53B | 46.69 | 22.54% | 0.28% | 6.71% | 8.16% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $1.32B | 15.62 | 5.81% | 6.15% | 3.01% | -7.14% | |
46 Neutral | $157.55M | -4.07 | -254.99% | ― | -20.13% | -88.66% | |
44 Neutral | $2.88M | ― | -133.50% | ― | -34.81% | 99.30% | |
42 Neutral | $4.31M | ― | -240.32% | ― | -78.46% | 83.71% | |
39 Underperform | $216.57K | -0.01 | -68.63% | ― | -88.85% | 68.28% |
* Consumer Defensive Sector Average
ISPR
Ispire Technology, Inc.
2.27
-2.00
-46.84%
UVV
Universal
53.79
3.77
7.55%
XXII
22nd Century
5.69
-908.56
-99.38%
TPB
Turning Point Brands
135.52
67.41
98.96%
GNLN
Greenlane Holdings
0.79
-561.63
-99.86%
KAVL
Kaival Brands Innovations Group
0.02
-0.82
-98.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.